Novel complication of nusinersen treatment: Hyponatremia
- Author:
Yasemin Coban
1
;
Nagehan Aslan
1
;
Dincer Yıldızdas
1
;
Ozden Ozgur Horoz
1
;
Gulen Gul Mert
2
,
3
Author Information
- Publication Type:Case Reports
- From:Neurology Asia 2020;25(1):85-86
- CountryMalaysia
- Language:English
- Abstract: Nusinersen is a novel therapy for spinal muscular atrophy (SMA) type 1. Thus, the adverse reactions of the therapy have not been well established. We present here a 5-months old boy with SMA type 1, who developed hyponatremia after a single dose of nursinersen which has been rarely reported previously.
- Full text:7.2020my0015.pdf
